EA3 study: Women’s health – Endometriosis and data in Sandbox
PreviousEA3 study: Women's health studiesNextEA3 study: Human papilloma virus-related gynecological lesions, and data in Sandbox
Last updated
Last updated
If you wish to use EA3 data, please familiarize yourself with these instructions.
/finngen/library-red/EA3_WOMENS_HEALTH_ENDOMETRIOSIS_1.0/
Expansion Area 3 (EA3) studies aim to acquire additional clinical data centered around specific diseases through biobanks.
Aim: The endometriosis deep phenotyping study aimed to explore the genetic background on endometriosis related chronic pain by identification of those endometriosis cases who suffer from chronic pain (lasting from three months and over) and those with abnormal pain response.
Methods: Data was captured from five biobanks, Auria, Helsinki, Central Finland, Borealis, and Eastern Finland biobanks. Currently, endometriosis data contains information about hospital administrated drugs, such as epidural and spinal infusions. Later, the information about the experience of pain will be added.
Data: The Endometriosis data has been placed in the Sandbox and is available for analysis. The Endometriosis samples are from DF12 and data has been collected from 5/6 hospital biobanks. Data collection time is until 23.3.2023.
Summary of the data (Oct 2023):
